“…A recent HPLC‐ECD methodology has reported quantification limits adequate for discrete brain region analysis of DA, DOPAC and 5‐hydroxyindolacetic acid (5‐HIAA) levels; however, determination of DA turnover ([DOPAC + HVA]/[DA]) within the SNpc and VTA regions would be problematic given the reported calibration range and LLOQ for HVA (~2.8 ng/mL after 5 μL sample volume injection; Nguyen, Aerts, Van Dam, & De Deyn, ). Moreover, methods which report very sensitive limits of detection (fmol to pmol range) are often found accompanied by the use of damaging high electrode potentials (> 700 mV; Bidel et al, ; Parrot et al, ; Vaarmann, Kask, & Mäeorg, ), the inability to measure all monoamines and metabolites simultaneously (Heidbreder et al, ; Hubbard et al, ) or long analytical run times (>25 min; Kumarathasan & Vincent, ; Nguyen et al, ; Unceta et al, ; Van Dam, Vermeiren, Aerts, & De Deyn, ). Shorter‐length columns and ultra‐high‐pressure liquid chromatography (UHPLC) systems are commonly employed to decrease analysis time (Farthing et al, ; Parrot et al, ; Reinhoud, Brouwer, van Heerwaarden, & Korte‐Bouws, ); however, it has been reported that chromatographic efficiency in complex matrices, particularly during isocratic elution using electrochemical detection, is often reduced as column length decreases (Bicker et al, ; Mutton, ; Nguyen, Guillarme, Rudaz, & Veuthey, ).…”